Profil
Michel Janicot worked as a Senior Director in Oncology Scientific Licensing at Johnson & Johnson and as a Senior Director in Research & Development at Janssen, Inc. Prior to that, he was the Head of Preclinical Research & Development at Isarna Therapeutics GmbH.
He also worked as a Principal at Rhone-Poulenc Rorer Pharmaceuticals, Inc. Dr. Janicot earned a doctorate degree from Université Paris Diderot-Paris 7 in 1988.
Anciens postes connus de Michel Janicot
| Sociétés | Poste | Fin |
|---|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Develops cytokine human transforming growth factor-beta (TGF-beta) inhibitors | Directeur Technique/Scientifique/R&D | - |
Formation de Michel Janicot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Université Paris Diderot-Paris 7
Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Develops cytokine human transforming growth factor-beta (TGF-beta) inhibitors | Health Technology |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
















